List of Tables
    Table 1. Female Contraceptive CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Female Contraceptive Market Trends
    Table 3. Female Contraceptive Market Drivers
    Table 4. Female Contraceptive Market Challenges
    Table 5. Female Contraceptive Market Restraints
    Table 6. Global Female Contraceptive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Female Contraceptive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Female Contraceptive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Female Contraceptive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Female Contraceptive Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Female Contraceptive Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Female Contraceptive Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Female Contraceptive Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Female Contraceptive Sales Share by Manufacturer, 2017-2022
    Table 15. Global Female Contraceptive Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Female Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Female Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptive as of 2021)
    Table 18. Top Players of Female Contraceptive in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Female Contraceptive Product Type
    Table 20. Date of International Manufacturers Enter into Female Contraceptive Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Female Contraceptive Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Female Contraceptive Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Female Contraceptive Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Female Contraceptive Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Female Contraceptive Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Female Contraceptive Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Female Contraceptive Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Female Contraceptive Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Female Contraceptive Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Female Contraceptive Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Female Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Female Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Female Contraceptive Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Female Contraceptive Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Female Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Female Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Female Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Female Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Female Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Female Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck Corporation Information
    Table 43. Merck Description and Business Overview
    Table 44. Merck Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Merck Female Contraceptive Product
    Table 46. Merck Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Allergan Corporation Information
    Table 53. Allergan Description and Business Overview
    Table 54. Allergan Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Allergan Product
    Table 56. Allergan Recent Development
    Table 57. Bayer Corporation Information
    Table 58. Bayer Description and Business Overview
    Table 59. Bayer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bayer Product
    Table 61. Bayer Recent Development
    Table 62. Okamoto Industries Corporation Information
    Table 63. Okamoto Industries Description and Business Overview
    Table 64. Okamoto Industries Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Okamoto Industries Product
    Table 66. Okamoto Industries Recent Development
    Table 67. Reckitt Benckiser Corporation Information
    Table 68. Reckitt Benckiser Description and Business Overview
    Table 69. Reckitt Benckiser Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Reckitt Benckiser Product
    Table 71. Reckitt Benckiser Recent Development
    Table 72. Lupin Pharmaceuticals Corporation Information
    Table 73. Lupin Pharmaceuticals Description and Business Overview
    Table 74. Lupin Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Lupin Pharmaceuticals Product
    Table 76. Lupin Pharmaceuticals Recent Development
    Table 77. Foundation Consumer Healthcare Corporation Information
    Table 78. Foundation Consumer Healthcare Description and Business Overview
    Table 79. Foundation Consumer Healthcare Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Foundation Consumer Healthcare Product
    Table 81. Foundation Consumer Healthcare Recent Development
    Table 82. Teva Pharmaceuticals Corporation Information
    Table 83. Teva Pharmaceuticals Description and Business Overview
    Table 84. Teva Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Teva Pharmaceuticals Product
    Table 86. Teva Pharmaceuticals Recent Development
    Table 87. Ansell Corporation Information
    Table 88. Ansell Description and Business Overview
    Table 89. Ansell Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Ansell Product
    Table 91. Ansell Recent Development
    Table 92. Ferring Pharmaceuticals Corporation Information
    Table 93. Ferring Pharmaceuticals Description and Business Overview
    Table 94. Ferring Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Ferring Pharmaceuticals Product
    Table 96. Ferring Pharmaceuticals Recent Development
    Table 97. Fuji Latex Corporation Information
    Table 98. Fuji Latex Description and Business Overview
    Table 99. Fuji Latex Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Fuji Latex Product
    Table 101. Fuji Latex Recent Development
    Table 102. Janssen Pharmaceuticals Corporation Information
    Table 103. Janssen Pharmaceuticals Description and Business Overview
    Table 104. Janssen Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Janssen Pharmaceuticals Product
    Table 106. Janssen Pharmaceuticals Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Female Contraceptive Customers List
    Table 110. Female Contraceptive Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Female Contraceptive Product Picture
    Figure 2. Global Female Contraceptive Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Female Contraceptive Market Size 2017-2028 (US$ Million)
    Figure 4. Global Female Contraceptive Sales 2017-2028 (K Units)
    Figure 5. United States Female Contraceptive Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Female Contraceptive Market Size 2017-2028 (US$ Million)
    Figure 7. United States Female Contraceptive Sales 2017-2028 (K Units)
    Figure 8. United States Female Contraceptive Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Female Contraceptive Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Female Contraceptive Report Years Considered
    Figure 11. Product Picture of Female Contraceptive Devices
    Figure 12. Product Picture of Female Contraceptive Drugs
    Figure 13. Global Female Contraceptive Market Share by Type in 2022 & 2028
    Figure 14. Global Female Contraceptive Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Female Contraceptive Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Female Contraceptive Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Female Contraceptive Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Female Contraceptive Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Female Contraceptive Market Share by Type in 2022 & 2028
    Figure 20. United States Female Contraceptive Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Female Contraceptive Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Female Contraceptive Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Female Contraceptive Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Female Contraceptive Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Online Stores
    Figure 26. Product Picture of Retail Outlets
    Figure 27. Global Female Contraceptive Market Share by Application in 2022 & 2028
    Figure 28. Global Female Contraceptive Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Female Contraceptive Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Female Contraceptive Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Female Contraceptive Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Female Contraceptive Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Female Contraceptive Market Share by Application in 2022 & 2028
    Figure 34. United States Female Contraceptive Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Female Contraceptive Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Female Contraceptive Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Female Contraceptive Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Female Contraceptive Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Female Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Female Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Female Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Female Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Female Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Female Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Female Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Female Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Female Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Female Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Female Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Female Contraceptive Value Chain
    Figure 73. Female Contraceptive Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed